Squamous cell carcinoma of the esophagus can be detected by microsatellite analysis in tumor and serum

Clinical Cancer Research

Volumn 9, Issue 11, 2003, Pages 4178-4183

  Eisenberger, Claus F ^a   Knoefel, Wolfram T ^a   Peiper, Matthias ^a   Merkert, Petra ^a   Yekebas, Emre F ^a   Scheunemann, Peter ^a   Steffani, Katharina ^a   Stoecklein, Nikolas H ^a   Hosch, Stefan B ^a   Izbicki, Jakob R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA EXTRACTION; ESOPHAGUS CARCINOMA; FOLLOW UP; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MICROSATELLITE MARKER; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SERUM; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME MAPPING; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; REFERENCE VALUES; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0141566690     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Heitmiller, R. F., Forastiere, A. A., and Kleinberg, L. R. Esophagus. In: D. Abeloff, J. O. Armitage, A. S. Lichter, and J. E. Niederhuber (eds.), Clinical Oncology, pp. 1517-1544. New York: Churchill Livingstone, 2000.
2. Akiyama, H., Tsurumaru, M., Udagawa, H., and Kajiyama, Y. Esophageal cancer. Curr. Probl. Surg., 34: 767-834, 1997.
3. Johnson, P. J., and Lo, Y. M. D. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin. Chem., 48: 1186-1193, 2002.
4. Gonzalgo, M. L., Eisenberger, C. F., Marshall, F. F., Hortopan, S., Sidransky, D., and Schoenberg, M. P. Prognostic significance of preoperative molecular urinalysis in renal cancer. Clin. Cancer Res., 8: 1878-1881, 2002.
5. Pearlstein, R. P., Benninger, M. S., Carey, T. E., Zarbo, R. J., Torres, F. X., Rybicki, B. A., and Van Dyke, D. L. Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer, 21: 333-339, 1998.
6. Ahsan, A., Neugut, A. I., and Gammon, M. D. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol. Biomark. Prev., 6: 779-782, 1997.
7. Sidransky, D. Nucleic acid based methods for the detection of cancer. Science (Wash. DC), 278: 1054-1058, 1997.
8. Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F., and Sidransky, D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci. USA, 91: 9871-9875, 1994.
9. Muzeau, F., Flejou, J. F., Thomas, G., and Hamelin, R. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. Int. J. Cancer, 72: 27-30, 1997.
10. Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., and Sidransky, D. Rates of p16 mutations in primary tumors with 9p loss. Science (Wash. DC), 265: 415-417, 1994.
11. Holland, E. A., Beaton, S. C., Edwards, B. G., Kefford, R. F., and Mann, G. J. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Oncogene, 9: 1361-1365, 1994.
12. Mori, T., Yanagisawa, A., Kato, Y., Miura, K., Nishihira, T., Mori, S., and Nakamura, Y. Accumulations of genetic alterations during esophageal carcinogenesis. Hum. Mol. Genet., 3: 1969-1971, 1994.
13. Aoki, T., Mori, T., Xiqun, D., Nisihira, T., Matsubara, T., and Nakamura, Y. Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer, 10: 177-182, 1994.
14. Ikeguchi, M., Unate, H., Maeta, M., and Kaibara, N. Detection of loss of heterozygosity at microsatellite loci in esophageal squamous cell carcinoma. Oncology (Basel), 56: 164-168, 1999.
15. Kagawa, Y., Yoshida, K., Hirai, T., Toge, T., Yokozaki, H., Yasui, W., and Tahara, E. Microsatellite instability in squamous cell carcinomas and dysplasias of the esophagus. Anticancer Res., 20: 213-218, 2000.
16. Barrett, M. T., Schutte, M., Kern, S. E., and Reid, B. J. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res., 56: 4351-4353, 1996.
17. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Wash. DC), 271: 350-353, 1996.
18. Karkera, J. D., Ayache, S., Ransome, R. J., Jackson, M. A., Elsayem, A. F., Sridhar, R., Detera-Wadleigh, S. D., and Wadleigh, R. G. Refinement of regions with allelic loss on chromosome 18p11.2 and 18q12.2 in esophageal squamous cell carcinoma. Clin. Cancer Res., 6: 3565-3569, 2000.
19. Gonzalez, M. V., Artimez, M. L., Rodrigo, L., Lopez-Larrea, C., Menendez, M. J., Alvarez, V., Perez, R., Fresno, M. F., Perez, M. J., Sampedro, A., and Coto, E. Mutation analysis of the p53, APC, and p16 genes in the Barrett's esophagus, dysplasia, and adenocarcinoma. J. Clin. Pathol. (Lond.), 50: 212-217, 1997.
20. Yanagi, M., Keller, G., Mueller, J., Walch, A., Werner, M., Stein, H. J., Siewert, J. R., and Höfler, H. Comparison of loss of heterozygosity and microsatellite instability in adenocarcinomas of the distal esophagus and proximal stomach. Virchows Arch., 437: 605-610, 2000.
21. Hibi, K., Robinson, C. R., Booker, S., Wu, L., Hamilton, S. R., Sidransky, D., and Jen, J. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res., 58: 1405-1407, 1998.
22. Maesawa, C., Tamura, G., Nishizuka, S., Ogasawara, S., Ishida, K., Terashima, M., Sakata, K., Sato, N., Saito, K., and Satodate, R. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res., 56: 3875-3878, 1996.
23. Spafford, M. F., Koch, W. M., Reed, A. L., Califano, J. A., Xu, L. H., Eisenberger, C. F., Yip, L., Leong, P. L., Wu, L., Liu, S. X., Jeronimo, C., Westra, W. H., and Sidransky, D. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin. Cancer Res., 7: 607-612, 2001.
24. Ahrendt, S. A., Chow, J. T., Hua, L., Yang, S. C., Eisenberger, C. F., Wu, L., Jen, J., and Sidransky, D. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J. Natl. Cancer Inst. (Bethesda), 91: 332-339, 1999.
25. Eisenberger, C. F., Schoenberg, M., Enger, C., Hortopan, S., Shah, S., Chow, N. H., Marshall, F. F., and Sidransky, D. Diagnosis of renal cancer by molecular urinalysis. J. Natl. Cancer Inst. (Bethesda), 91: 2028-2032, 1999.
26. Eisenberger, C. F., Wu, L., Nicol, T., Shah, S. I., Sidransky, D., and Westra, W. H. Comparative microsatellite analysis in discerning origin of disseminated tumor: the case of a patient with malignant ascites and a history of multiple tumors. Hum. Pathol., 30: 1111-1113, 1999.
27. Chen, X. Q., Stroun, M., Magnenat, J. L., Nicod, L. P., Kurt, A. M., Lyautey, J., Lederrey, C., and Anker, P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med., 2: 1033-1035, 1996.
28. Bruhn, N., Beinert, T., Oehm, C., Jandrig, B., Petersen, I., Chen, X. Q., Possinger, K., and Fleischhacker, M. Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer. Ann. N. Y. Acad. Sci., 906: 72-82, 2000.
29. Steiner, G., Schoenberg, M. P., Linn, J. F., Mao, L., and Sidransky, D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med., 3: 621-624, 1997.
30. Utting, M., Werner, W., Dahse, R., Scubert, J., and Junker, K. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin. Cancer Res., 8: 35-40, 2002.
31. Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D., and Sidransky, D. Molecular detection of bladder cancer by microsatellite analysis. Science (Wash. DC), 271: 659-662, 1996.
32. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med., 2: 1035-1037, 1996.
33. Racila, E., Euhus, D., Weiss, A. J., Rao, C., McConnell, J., Terstappen, L. W., and Uhr, J. W. Detection and chracterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. USA, 95: 4589-4594, 1998.
34. Dahse, R., Utting, M., Werner, W., Schimmel, B., Claussen, U., and Junker, K. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples. Int. J. Oncol., 20: 107-115, 2001.
35. Kölble, K., Ulrich, O. M., Pidde, H., Barthel, B., Diermann, J., Rudolph, B., Dietel, M., Schlag, P. M., and Scherneck, S. Microsatellite alterations in serum DNA of patients with colorectal cancer. Lab. Investig., 79: 1145-1150, 1999.
36. Hickey, K. P., Boyle, K. P., Jepps, H. M., Andrew, A. C., Buxton, E. J., and Burns, P. A. Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients. Br. J. Cancer, 80: 1803-1808, 1999.
37. Sozzi, G., Musso, K., Ratcliffe, C., Goldstraw, P., Pierotti, M. A., and Pastorino, U. Detection of microsatellite alterations in plasma DNA of small cell lung cancer patients: a prospect for early diagnosis. Clin. Cancer Res., 5: 2689-2692, 1999.
38. Jen, J., Wu, L., and Sidransky, D. An overview on the isolation and analysis of circulating tumor DNA in plasma and serum. Ann. N. Y. Acad. Sci., 906: 8-12, 2000.
39. Stroun, M., Maurice, P., Vasioukhin, V., Lyautey, J., Lederrey, C., Lefort, F., Rossier, A., Chen, X. Q., and Anker, P. The origin and mechanism of circulating DNA. Ann. N. Y. Acad. Sci., 906: 161-168, 2000.
40. Chen, X. Q., Bonnefoi, H., Diebold-Berger, S., Lyautey, V., Lederrey, C., Faltin-Traub, E., Stroun, M., and Anker, P. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin. Cancer Res., 5: 2297-2303, 1999.
41. Anker, P., Lefort, F., Vasioukhin, V., Lyautey, J., Lederrey, C., Chen, X. Q., Stroun, M., Mulcahy, H. E., and Farthing, M. J. G. K-ras gene mutations in the plasma of colorectal cancer patients. Gastroenterology, 112: 1114-1120, 1997.